Titan Pharmaceuticals, Inc. Deferred Revenue
Titan Pharmaceuticals, Inc. had Deferred Revenue of $0 as of 2019-12-31, per its 10-K filed 2021-03-31.
Discontinued › Balance Sheet › Liabilities
us-gaap:DeferredRevenue · last filed 2021-03-31
- 2019-12-31: Deferred Revenue $0.00.
- 2019-09-30: Deferred Revenue $0.00.
- 2019-06-30: Deferred Revenue $0.00.
- 2019-03-31: Deferred Revenue $0.00.
| Period end | Deferred Revenue |
|---|---|
| 2019-12-31 | $0.00 10-K · filed 2021-03-31 |
| 2019-09-30 | $0.00 10-Q · filed 2019-11-14 |
| 2019-06-30 | $0.00 10-Q · filed 2019-08-14 |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-15 |
| 2018-12-31 | $313.00K 10-K · filed 2021-03-31 |
| 2018-09-30 | $626.00K 10-Q · filed 2018-11-14 |
| 2018-06-30 | $939.00K 10-Q · filed 2018-08-14 |
| 2018-03-31 | $1.41M 10-Q · filed 2018-05-15 |
| 2017-12-31 | $0.00 10-K · filed 2020-03-30 |